Table 3.

Group comparison between weight of each experimental groups of alive fetuses using Chi-square test

Comparison between 2 groups	Male + Female			Male			Female
	95% CI	p-value		95% CI	p-value		95% CI	p-value
T1/C1	(0.71)-(0.82)	0.02		(–2.52)-(–1.65)	< 0.0001		(–1.93)-(–1.17)	< 0.0001
T2/C1	(–3.00)-(–1.92)	< 0.0001		(–0.17)-(0.93)	0.17		(0.01)-(1.01)	0.043
T2/T1	(–3.49)-(–2.32)	< 0.0001		(1.92)-(3.02)	< 0.0001		(1.58)-(2.55)	< 0.0001
T3/C2	(–0.22)-(0.32)	0.73		(–0.24)-(0.57)	0.42		(–0.43)-(0.29)	0.71
T4/C2	(–2.12)-(–1.46)	< 0.0001		(–1.88)-(–0.86)	< 0.0001		(–2.59)-(–1.74)	< 0.0001
T4/T3	(–2.17)-(–1.51)	< 0.0001		(–2.02)-(–1.05)	< 0.0001		(–2.53)-(–1.67)	< 0.0001

CI, confidence interval. C1: Control group that received no medication. T1: Treated groups receiving 365 mg/kg starting from first day of insemination. T2: Treated groups receiving 365 mg/kg starting from 30 days prior to pregnancy. C2: Control group that received no medication and underwent caesarian section on the 15th day of gestational age. T3: Treated groups receiving 365 mg/kg starting from first day of insemination and underwent caesarian section on the 15th day of gestational age. T4: Treated groups receiving 365 mg/kg starting from 30 days prior to pregnancy and underwent caesarian section on the 15th day of gestational age.